Gabapentin Tablet, Film Coated
Product Images NDC 71093-112

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71093-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aci Healthcare Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg100count Vivimed

Gabapentin 600 mg film-coated tablets label showing the product name, strength, dosage form, and package size of 100 tablets. Label includes storage instructions, manufacturer information (Vvimed Life Sciences Private Limited, India), distributor details (ACI Healthcare USA, Inc.), and instructions for pharmacists. The label also features the ACI Healthcare logo and a bar code.*

FDA Label Image

800mg500count Vivimed

Gabapentin 800 mg film-coated tablets packaging label from ACI Healthcare USA, Inc. The label indicates 500 tablets per bottle, with instructions to dispense the medication guide separately to each patient. Storage and handling information is provided, along with manufacturer and distributor details. The label includes NDC code 71093-112-05 and a barcode.*

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

An illustrated formula for calculating creatinine clearance (CLCr) based on patient age, weight, serum creatinine, and an adjustment factor for female patients.*

FDA Label Image

Containerlabel 600mg Strides

Gabapentin Tablets USP 600 mg film-coated tablets label showing a package of 100 tablets. The label includes dosage storage instructions, manufacturer information (Strides Pharma Science Limited, India), and distributor details (ACI Healthcare USA, Inc., Coral Springs, FL). It advises pharmacists to dispense the medication guide separately and notes child-resistant container requirements.*

FDA Label Image

Containerlabel 800mg Strides

Gabapentin Tablets USP 800 mg film-coated tablets label from ACI Healthcare USA, Inc. The label states the product contains 500 tablets, each with 800 mg gabapentin. It includes storage instructions, dispensing guidance, distributor and manufacturer addresses, and standard medication warnings. Barcodes and a note space for batch details are present.*

FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

Chemical structure of gabapentin showing a cyclohexane ring attached to an aminomethyl and a carboxymethyl group, representing the molecular framework of the active ingredient gabapentin.*

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

A line graph comparing mean pain scores over eight weeks between placebo and Gabapentin 3600 mg/day groups. The X-axis represents weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The Y-axis shows mean pain scores from 0 to 10, with the Gabapentin group showing a noticeable decrease in pain scores over time compared to placebo.*

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

A line graph comparing mean pain scores over seven weeks for placebo and two dosages of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis shows weeks divided into a 3-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores. Gabapentin groups show decreasing pain scores, lower than placebo over the study duration.*

FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) treatments in two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600. Study 2 shows 14% responders for PBO, 32% for GBP 1800, and 34% for GBP 2400. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

A scatter plot showing the percentage difference on the y-axis against daily dose in mg on the x-axis for Gabapentin. Data are presented for three studies labeled as Study a, Study b, and Study c, with values plotted at doses of 600, 900, 1200, and 1800 mg. The chart compares differences among studies at various doses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.